OccuLogix, Inc.

OccuLogix, Inc.

March 11, 2005 13:55 ET

OccuLogix to Present at Smith Barney Citigroup 2005 Healthcare Conference


NEWS RELEASE TRANSMITTED BY CCNMatthews

FOR: OCCULOGIX, INC.

NASDAQ SYMBOL: RHEO
TSX SYMBOL: RHE

MARCH 11, 2005 - 13:55 ET

OccuLogix to Present at Smith Barney Citigroup 2005
Healthcare Conference

TORONTO, ONTARIO--(CCNMatthews - March 11, 2005) - OccuLogix, Inc.
(NASDAQ:RHEO)(TSX:RHE) announced today that it will present at the Smith
Barney Citigroup 2005 Healthcare Conference at the Mayflower Hotel in
Washington, DC on March 31 at 10:55 AM Eastern Time.

An audio Webcast will be available live and archived for 30 days at the
Investor Relations section of www.occulogix.com.

About OccuLogix

OccuLogix is an ophthalmic therapeutic company founded to commercialize
innovative evidence-based treatments for eye diseases, including
age-related macular degeneration. AMD is the leading cause of late onset
visual impairment and legal blindness in people over the age of 50.
OccuLogix's common shares trade on the NASDAQ National Market under the
symbol 'RHEO' and on the Toronto Stock Exchange under the symbol 'RHE'.

Forward Looking Statements

This press release may contain forward-looking statements. These
statements relate to future events and are subject to risks,
uncertainties and assumptions about the company. These statements are
only predictions based on our current expectations and projections about
future events. You should not place undue reliance on these statements.
Actual events or results may differ materially. Many factors may cause
our actual results to differ materially from any forward-looking
statement, including the factors detailed in our filings with the
Securities and Exchange Commission and Canadian regulatory authorities,
including our Registration Statement on Form S-1. We do not undertake to
update any forward-looking statements.

-30-

Contact Information

  • FOR FURTHER INFORMATION PLEASE CONTACT:
    OccuLogix, Inc.
    Stephen Kilmer
    VP, Corporate Affairs
    (905) 602-0887 ext. 3904
    stephen.kilmer@occulogix.com